Antipsychotic Drugs Industry -North America ruled the market by holding the biggest income share in 2015. As indicated by the Anxiety and Depression Association of America, around 6.7% of the U.S. populace aged 18 years or more was experiencing real depression in 2016.Asia Pacific is foreseen to display the speediest development in the following because of rising social awareness with respect to psychotic disorders and other related issue, for example, bipolar (mania), major depression, and anxiety.
The Antipsychotic Drugs Market is segmented as follows-
Antipsychotic Drugs Market, By Type, First Generation, Second Generation, Third Generation
Antipsychotic Drugs Market, By Application, SchizophreniaBipolar disorders, Dementia, Unipolar Depression, Other Applications/
Click for sample Copy of this Report: https://www.crystalmarketresearch.com/report-sample/HC02555
Antipsychotic Drugs Industry -Drug Class Outlook and Trend Analysis:
The second generation represents the biggest share in the market. This class defined as atypical antipsychotics includes risperidone, clozapine, asenapne, olanzapine, sertindole, paliperidone, quetiapine. These are useful in the treatment of schizophrenia and have rapidly begun replacing the first-generation antipsychotics. The third generation, aripiprazole (Abilify) is used for the treatment of schizophrenia and is also used as maintenance drug for this disease.
Antipsychotic Drugs -Industry Outlook and Trend Analysis:
The global Antipsychotic Drugs Market was worth USD 11.34 billion in 2014 and is expected to reach approximately USD 14.05 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 2.41% during the forecast period. Developing predominance of psychosis and associated diseases is driving the requirement for antipsychotic drugs. The main considerations contributing towards the developing rate of these diseases incorporate substance-induced psychoses, physical illness resulting in depression, and genetic mutations. The advent of more up to date antipsychotic compounds and immense speculations for R&D are boosting the market development. Likewise, expanding initiatives taken by the market players to extend remedial usage of these drugs are foreseen to make opportunities for the development of antipsychotics in the following years, accordingly boosting the demand.
Antipsychotic Drugs Industry -Application Outlook and Trend Analysis:
The antipsychotics are useful in treating schizophrenia, major depression (unipolar), different types of bipolar disorders, dementia, and other psychotic issues. These products have first-line remedial applications amid treatment and maintenance periods of schizophrenia. The etiology of schizophrenia is as yet obscure; in this way the treatment fundamentally goes for disposing of the indications of the ailment. The usage of antipsychotics in treating schizophrenia represents the biggest income share.
Antipsychotic Drugs Industry -Competitive Insights:
The leading players in the market are AstraZeneca, Pfizer, Bristol-Myers Squibb, Johnson & Johnson, Allergan, Eli Lilly and Company and GlaxoSmithKline. Competition in the market is foreseen to increase in the following years since a few organizations are presently concentrating on advancement of more up to date and better antipsychotics with lesser or immaterial unfavourable impacts to increase upper hand over others.
Reasons to buy a Exclusive report?
1) An extensive research study on the Global Antipsychotic Drugs market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Antipsychotic Drugs market.
2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.
3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.
2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.
3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.
Major TOC of Antipsychotic Drugs Market:
Chapter1. Introduction
Chapter2. Executive Summary
Chapter3. Market Overview
Chapter 4. Antipsychotic Drugs Market, By Type
Chapter2. Executive Summary
Chapter3. Market Overview
Chapter 4. Antipsychotic Drugs Market, By Type
4.1. Introduction
4.2. Global Antipsychotic Drugs Sales, Revenue and Market Share by Type (2014-2017)
4.2.1. Global Antipsychotic Drugs Sales and Sales Share by Type (2014-2017)
4.2.2. Global Antipsychotic Drugs Revenue and Revenue Share by Type (2014-2017)
4.3. Antipsychotic Drugs Market Assessment and Forecast, By Type, 2014-2023
4.4. First Generation
4.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5. Second Generation
4.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.6. Third generation
4.6.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
Chapter 5. Antipsychotic Drugs Market, By Application
5.1. Introduction
5.2. Global Antipsychotic Drugs Sales, Revenue and Market Share by Application (2014-2017)
5.2.1. Global Antipsychotic Drugs Sales and Sales Share by Application (2014-2017)
5.2.2. Global Antipsychotic Drugs Revenue and Revenue Share by Application (2014-2017)
5.3. The Antipsychotic Drugs Market Assessment and Forecast, By Application, 2014-2023
5.4. Schizophrenia
5.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.5. Bipolar disorders
5.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.6. Dementia
5.6.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.7. Unipolar Depression
5.7.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.8. Other Applications
5.8.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
Chapter8. Antipsychotic Drugs Market, By Region
Chapter9. Company Profiles
Chapter10. Global Antipsychotic Drugs Market Competition, by Manufacturer
Chapter11. Antipsychotic Drugs Market Forecast (2018-2023)
Chapter9. Company Profiles
Chapter10. Global Antipsychotic Drugs Market Competition, by Manufacturer
Chapter11. Antipsychotic Drugs Market Forecast (2018-2023)
…CONTINUED FOR TOC
Click to Enquire in-depth TOC "Exclusive report": https://www.crystalmarketresearch.com/send-an-enquiry/HC02555
Comments
Post a Comment